Association of reversed Robin Hood syndrome with risk of stroke recurrence

Neurology

Volumn 75, Issue 22, 2010, Pages 2003-2008

  Palazzo, P ^a,c   Balucani, C ^a   Barlinn, K ^a   Tsivgoulis, G ^d   Zhang, Y ^a   Zhao, L ^a   Dewolfe, J ^b   Toaldo, B ^e   Stamboulis, E ^f   Vernieri, F ^c   Rossini, P M ^c   Alexandrov, A V ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA HOSPITAL   (United States)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^e UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

^f UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT;

ADULT; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RECURRENT DISEASE; REVERSED ROBIN HOOD SYNDROME; STROKE;

EID: 78650008752     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181ffe4e4     Document Type: Article

References (23)

1. Dávalos A, Toni D, Iweins F, Lesaffre E, Bastianello S, Castillo J. Neurological deterioration in acute ischemic stroke: Potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I. Stroke 1999;30:2631-2636.
2. Grotta JC, Welch KM, Fagan SC, et al. Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial. Stroke 2001;32:661-668.
3. Kasner SE, Demchuk AM, Berrouschot J, et al. Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke 2001;32:2117-2123.
4. Toni D, Fiorelli M, Gentile M, et al. Progressing neurological deficit secondary to acute ischemic stroke: A study on predictability, pathogenesis, and prognosis. Arch Neurol 1995;52:670-675.
5. Alexandrov AV, Grotta JC. Arterial re-occlusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002;59:862-867.
6. Toni D, Fiorelli M, Zanette EM, et al. Early spontaneous improvement and deterioration of ischemic stroke patients: A serial study with transcranial doppler ultrasonography. Stroke 1998;29:1144-1148. (Pubitemid 28265469)
7. Baracchini C, Manara R, Ermani M, Meneghetti G. The quest for early predictors of stroke evolution: Can TCD be a guiding light? Stroke 2000;31:2942-2497.
8. Alexandrov AV, Sharma VK, Lao AY, Tsivgoulis G, Malkoff MD, Alexandrov AW. Reversed Robin Hood syndrome in acute ischemic stroke patients. Stroke 2007;38: 3045-3048.
9. Alexandrov AV, Nguyen HT, Rubiera M, et al. Prevalence and risk factors associated with reversed Robin Hood syndrome in acute ischemic stroke. Stroke 2009;40:2738-2742.
10. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
11. Markus HS, Harrison MJ. Estimation of cerebrovascular reactivity using transcranial doppler, including the use of breath-holding as the vasodilatory stimulus. Stroke 1992; 23:668-673.
12. Silvestrini M, Vernieri F, Pasqualetti P, et al. Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 2000;283: 2122-2127. (Pubitemid 30241308)
13. Tsivgoulis G, Sharma VK, Lao AY, Malkoff MD, Alexandrov AV. Validation of transcranial doppler with computed tomography angiography in acute cerebral ischemia. Stroke 2007;38:1245-1249.
14. Tsivgoulis G, Alexandrov AV, Sloan MA. Advances in transcranial doppler ultrasonography. Curr Neurol Neurosci Rep 2009;9:46-54.
15. Christou I, Felberg RA, Demchuk AM, et al. Accuracy parameters of a broad diagnostic battery for bedside transcranial doppler to detect flow changes with internal carotid artery stenosis or occlusion. J Neuroimaging 2001; 11:236-242.
16. Tsivgoulis G, Saqqur M, Sharma VK, Lao AY, Hill MD, Alexandrov AV, CLOTBUST Investigators. Association of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke. Stroke 2007;38:961-966.
17. Sacco RL, Adams R, Albers G, et al, American Heart Association, American Stroke Association Council on Stroke, Council on Cardiovascular Radiology and Intervention, American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: Co-sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke 2006;37:577-617.
18. Sacco RL, Foulkes MA, Mohr JP, Wolf PA, Hier DB, Price TR. Determinants of early recurrence of cerebral infarction: The Stroke Data Bank. Stroke 1989;20:983-989.
19. Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004;62:569-573.
20. Kasner SE, Chimowitz MI, Lynn MJ, et al, Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006;113: 555-563.
21. Culebras A. Cerebrovascular disease and the pathophysiology of obstructive sleep apnea. Curr Neurol Neurosci Rep 2007;7:173-179.
22. Tsivgoulis G, Alexandrov AV. Cerebral autoregulation impairment during wakefulness in obstructive sleep apnea syndrome is a potential mechanism increasing stroke risk. Eur J Neurol 2009;16:283-284.
23. Obrig H, Villringer A. Beyond the visible; imaging the human brain with light. J Cereb Blood Flow Metab 2003; 23:1-18.